DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Carboxyamidotriazole is an investigational drug.
There have been 10 clinical trials for Carboxyamidotriazole. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 1999.
The most common disease conditions in clinical trials are Glioma, Kidney Neoplasms, and Carcinoma, Renal Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), Tactical Therapeutics, Inc., and Annick Desjardins.
Recent Clinical Trials for Carboxyamidotriazole
|Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma||Tactical Therapeutics, Inc.||Phase 1|
|Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma||Annick Desjardins||Phase 1|
|Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure||Tactical Therapeutics, Inc.||Phase 1|